EQUIP

Equip is a United States-based virtual healthcare platform that provides evidence-based eating disorder treatment for patients aged 6 to 24 through comprehensive telehealth services. The company connects these patients with a dedicated five-person care team:comprising a therapist, dietician, medical provider, peer mentor, and family mentor:to deliver structured family-based therapy directly in the home environment. Operating across all 50 states as the largest treatment provider in the country, the platform partners with commercial health insurance payors to reduce out-of-pocket expenses and increase accessibility compared to traditional in-patient treatment centers. In February 2022, the organization raised $58 million in Series B funding led by The Chernin Group, with additional equity participation from Tiger Global, General Catalyst, and Stripes Group to scale its commercial operations. Equip was officially founded in 2019 by Kristina Saffran and Dr. Erin Parks.

High-Level Overview

Equip is a San Diego-based health technology company providing virtual, evidence-based treatment programs for eating disorders, delivering care remotely through a dedicated five-person team per patient—including a therapist, dietitian, physician, peer mentor, and family mentor.[2][3] It serves patients in their homes, addressing a critical gap in accessible mental health care for conditions like anorexia and bulimia, where traditional in-person treatment is often limited by geography, cost, and specialist shortages.[2][5] At Series C stage with over $189 million in total funding—including a $47 million raise in 2025 and $110 million in February 2025—Equip demonstrates strong growth momentum, employing over 250 staff, partnering with health plans, and earning recognitions like TIME's Top HealthTech Companies of 2025.[2][5][6]

Origin Story

Equip was founded in 2019 by Kristina Saffran (CEO) and Erin Parks (Chief Clinical Officer), both experts in eating disorders—Saffran as a recovered patient and Parks with clinical background; the company started as Barcada Health in San Diego (later Carlsbad), CA.[2][3] The idea emerged from the founders' recognition of outdated, inaccessible treatment models, aiming to scale family-based care virtually for lasting recovery at home.[3] Early traction came via initial investments from F-Prime Capital in 2019, enabling rapid scaling; pivotal moments include raising $35 million in April 2024, a $47 million equity round in July 2025, and $110 million in February 2025, alongside high-profile support like actress Kerry Washington's investment and advisory role.[2][5][6]

Core Differentiators

• Comprehensive Virtual Care Model: Unlike traditional in-person programs, Equip assigns a multidisciplinary five-person team (therapist, dietitian, physician, peer/family mentors) for personalized, home-based treatment, emphasizing family-based therapy proven for lasting recovery.[2][3]
• Evidence-Based and Research-Driven: Built by field experts and survivors, it publishes research (e.g., on eating disorders in Latinx communities) and adapts to trends like GLP-1 medications' potential role.[2][5]
• Scalability and Accessibility: Remote delivery expands reach amid specialist shortages, with partnerships for health plan integration; rapid growth to 250+ employees supports rising demand.[2][5]
• Strong Backing and Recognition: Investors like Tiger Global, General Catalyst, F-Prime, and Optum validate its model; accolades include Fast Company's Best Workplaces for Innovators and TIME's 2025 Top HealthTech.[2]

Role in the Broader Tech Landscape

Equip rides the telehealth boom in mental health, particularly for eating disorders—a segment strained by uneven demand, specialist scarcity, high costs, and cultural factors like fitness trends amplified by GLP-1 weight-loss drugs (e.g., Ozempic), which may influence treatment paradigms.[5] Timing is ideal post-pandemic, with virtual care normalizing and payers favoring cost-effective models; Equip influences the ecosystem by publishing research, expanding health plan access, and proving digital scalability in a field where patients face 16.6 years shorter life expectancy without intervention.[2][5] It counters operational challenges in eating disorder care, potentially setting standards for family-involved virtual therapy amid rising awareness and funding.

Quick Take & Future Outlook

Equip's trajectory points to aggressive expansion: scaling team size, deepening health plan partnerships, and integrating emerging therapies like GLP-1s while researching underserved groups.[2][5] Trends like AI-enhanced care personalization, payer adoption of virtual mental health, and post-GLP-1 shifts in body image treatment will shape it, potentially evolving Equip into a dominant player in digital behavioral health.[5] With $189M+ raised and Series C stability, its influence could redefine accessible recovery, turning a niche crisis into a scalable solution—building on its bold origins to deliver "lasting recovery at home."[3]